All Medicines and Healthcare Products Regulatory Agency articles – Page 3
-
HSJ LocalTrust in £2m legal battle with pharma company
A specialist trust is being sued for nearly £2m by a Luxembourgian pharmaceutical company over allegations of wrongdoing by the provider’s subsidiary company, HSJ can reveal.
-
NewsFT fined after cancer clinical trial death
A hospital trust has been fined £45,000 following the death of a leukaemia patient who was given five times the amount of drugs she was prescribed during a clinical trial.
-
NewsClinical trial to resume after pathologist reverses decision on death
Researchers plan to restart high-dose radiotherapy in a cancer trial after refuting the outcome of a coroner’s inquest.
-
NewsTrust stops making cancer drugs after criticism from regulator
An acute trust is to abandon manufacturing its own radiopharmaceuticals after a regulator said it needed more quality improvement work and better facilities.
-
NewsNew Brexit plan worse for NHS than May’s deal, experts warn
The NHS will be exposed to more risk by the government’s latest Brexit deal than by Theresa May’s original agreement, health service experts and lobby groups have told HSJ.
-
NewsMinisters confirm ban on some drug exports ahead of Brexit deadline
Ministers have confirmed plans for a ban on the export of certain medicines, starting with a group of 24 drugs including 19 hormone replacement therapy treatments, ahead of the no-deal Brexit deadline at the end of this month.
-
NewsDHSC tenders for centralised purchasing service
NHS organisations will be given the chance to advertise and manage tenders on a new platform under government plans to create a centralised buying tool.
-
NewsNHS faces legal action from ‘abandoned’ IV feed patients
The NHS and the national medical regulator could face legal action over the shortage of intravenous feed supplies for hundreds of UK patients, HSJ has learned.
-
NewsRegulator announces interim CEO
The Medicines and Healthcare products Regulatory Agency has appointed an interim chief executive.
-
News‘Reprehensible’ action by regulator sparks call for inquiry
Senior clinicians have called for a review into how hundreds of patients have been left without intravenous food after action by the medical regulator severly curtailed its supply.
-
NewsDozens of patients admitted in feed supply emergency
Dozens of patients including children have now been admitted to hospital because of the national shortage of intravenous food supplies for patients who cannot eat normal food, HSJ has learned.
-
NewsExclusive: NHSE declares emergency over IV shortage
The shortage of intravenous feed supplies affecting hundreds of patients across the country has been declared a national emergency incident by NHS leaders.
-
NewsRegulator accused of presiding over 'utter shambles' says it was 'duty bound' to act on IV supplies
A regulator has defended its actions which caused delays to the supply of life-saving intravenous feed for hundreds of patients with HSJ learning some are now being admitted to hospital.
-
NewsGoogle AI lead: Machine learning 18 months away from NHS hospitals
Artificial intelligence will be used to foresee and prevent the onset of life-threatening conditions in NHS hospitals in “substantial pilots” in about 18 months, Google DeepMind’s clinical lead has predicted.
-
NewsHundreds of patients at risk amid major delays to IV feed supplies
Hundreds of patients, including children, dependent on intravenous nutrition to keep them alive are experiencing delays in vital deliveries, because of restrictions placed on the manufacturer by the medical devices regulator.
-
NewsSafety of health apps to be tested in government 'sandbox'
The regulation of “less than perfectly accurate” health apps is to be overhauled, Matt Hancock’s senior tech advisor has said.
-
HSJ LocalTrust could face 'catastrophic' situation over outdated equipment
A hospital trust has warned it could face a “catastrophic” situation through the contamination of outdated equipment.
-
NewsSteve Field: Digital GPs overseas remain a danger
Regulators and policymakers are at a loss for how to stop people accessing dangerous medicines using online services overseas, the outgoing chief inspector of GPs has said.
-
NewsTrust postpones trials after regulator partially suspends licence
A trust has been unable to start some new cancer trials as planned after regulators partially suspended its licence to manufacture medicines.
-
NewsHigher safety hurdle needed for health apps – Hancock
Regulators need to demand more evidence that health apps are safe for use in the NHS, the health and social care secretary has said











